Heissigerova, J. Et Al. 2019. Efficacy and Safety of Sarilumab for the Treatment of Posterior Segment Noninfectious Uveitis (SARIL-NIU): The Phase 2 SATURN Study. OPHTHALMOLOGY , vol.126, no.3 , 428-437.

Heissigerova, J., Callanan, D., de Smet, M. D., Srivastava, S. K., Karkanova, M., Garcia-Garcia, O., ... KADAYIFÇILAR, S.(2019). Efficacy and Safety of Sarilumab for the Treatment of Posterior Segment Noninfectious Uveitis (SARIL-NIU): The Phase 2 SATURN Study. OPHTHALMOLOGY , vol.126, no.3, 428-437.

Heissigerova, Jarmila Et Al. "Efficacy and Safety of Sarilumab for the Treatment of Posterior Segment Noninfectious Uveitis (SARIL-NIU): The Phase 2 SATURN Study," OPHTHALMOLOGY , vol.126, no.3, 428-437, 2019

Heissigerova, Jarmila Et Al. "Efficacy and Safety of Sarilumab for the Treatment of Posterior Segment Noninfectious Uveitis (SARIL-NIU): The Phase 2 SATURN Study." OPHTHALMOLOGY , vol.126, no.3, pp.428-437, 2019

Heissigerova, J. Et Al. (2019) . "Efficacy and Safety of Sarilumab for the Treatment of Posterior Segment Noninfectious Uveitis (SARIL-NIU): The Phase 2 SATURN Study." OPHTHALMOLOGY , vol.126, no.3, pp.428-437.

@article{article, author={Jarmila Heissigerova Et Al. }, title={Efficacy and Safety of Sarilumab for the Treatment of Posterior Segment Noninfectious Uveitis (SARIL-NIU): The Phase 2 SATURN Study}, journal={OPHTHALMOLOGY}, year=2019, pages={428-437} }